Stock HSTO HISTOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Histogen Inc.

Equities

HSTO

US43358Y2028

Delayed OTC Markets
Other stock markets
 12:55:38 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.3511 USD +0.03% Intraday chart for Histogen Inc. +0.31% +14.10%
Apr. 19 Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc. CI
Apr. 18 Histogen Inc. Filed for Bankruptcy CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
AQ
Histogen Announces Second Adjournment of Special Meeting of Stockholders
AQ
Histogen Announces Adjournment of Special Meeting of Stockholders
AQ
Histogen: Q3 Earnings Snapshot
AQ
Histogen Announces Board Approval of Complete Liquidation and Dissolution
AQ
Histogen : Change in Certifying Accountants - Form 8-K
PU
Histogen to Explore Strategic Alternatives
AQ
HISTOGEN INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Histogen: Q1 Earnings Snapshot
AQ
HISTOGEN INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Histogen Reports First Quarter 2023 Results and Provides Business Update
AQ
Histogen Announces Online Publication in the Journal of Investigative Dermatology
AQ
Histogen : Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases - Form 8-K
PU
HISTOGEN INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
GL
Histogen Announces Issuance of US Patent Covering CTS-2090 Methods of Use
GL
HISTOGEN INC. : Change in Directors or Principal Officers (form 8-K)
AQ
HISTOGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Histogen Reports Year-End 2022 Results and Provides Business Update
GL
Histogen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HSTO Stock
  4. News Histogen Inc.
  5. Press Releases